114 related articles for article (PubMed ID: 3557196)
21. Fallopian tube carcinoma.
Eddy GL; Copeland LJ; Gershenson DM; Atkinson EN; Wharton JT; Rutledge FN
Obstet Gynecol; 1984 Oct; 64(4):546-52. PubMed ID: 6541328
[TBL] [Abstract][Full Text] [Related]
22. Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
Barlin JN; Dao F; Bou Zgheib N; Ferguson SE; Sabbatini PJ; Hensley ML; Bell-McGuinn KM; Konner J; Tew WP; Aghajanian C; Chi DS
Gynecol Oncol; 2012 Jun; 125(3):621-4. PubMed ID: 22446622
[TBL] [Abstract][Full Text] [Related]
23. Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.
Barakat RR; Rubin SC; Saigo PE; Chapman D; Lewis JL; Jones WB; Hakes TB; Markman M; Reichman B; Hoskins WJ
Gynecol Oncol; 1991 Aug; 42(2):156-60. PubMed ID: 1894176
[TBL] [Abstract][Full Text] [Related]
24. Surgico-pathological stage I primary fallopian tube adenocarcinoma.
Wang PH; Yuan CC; Chao HT
Int J Gynaecol Obstet; 1998 Oct; 63(1):73-4. PubMed ID: 9849719
[No Abstract] [Full Text] [Related]
25. [Analysis of therapeutic result and prognostic factor in primary fallopian tube carcinoma].
Yu AJ; Fang SH; Gao YL
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):789-93. PubMed ID: 18396696
[TBL] [Abstract][Full Text] [Related]
26. Thymoma. A retrospective study of 87 cases.
Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
Cancer; 1994 May; 73(10):2491-8. PubMed ID: 8174044
[TBL] [Abstract][Full Text] [Related]
27. High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer.
Somlo G; Doroshow JH; Forman SJ; Leong LA; Margolin KA; Morgan RJ; Raschko JW; Akman SA; Ahn C; Sniecinski I
Cancer; 1994 Jan; 73(1):125-34. PubMed ID: 7903906
[TBL] [Abstract][Full Text] [Related]
28. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy with etoposide, cisplatin, and doxorubicin in mixed müllerian tumors of the adnexa.
Cass I; Resnik E; Chambers JT; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE
Gynecol Oncol; 1996 Jun; 61(3):309-14. PubMed ID: 8641607
[TBL] [Abstract][Full Text] [Related]
30. Treatment of recurrent and metastatic adenocarcinoma of the endometrium with cisplatin, doxorubicin, cyclophosphamide, and medroxyprogesterone acetate.
Fung MF; Krepart GV; Lotocki RJ; Heywood M
Obstet Gynecol; 1991 Dec; 78(6):1033-8. PubMed ID: 1945203
[TBL] [Abstract][Full Text] [Related]
31. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
Hancock KC; Freedman RS; Edwards CL; Rutledge FN
Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
[TBL] [Abstract][Full Text] [Related]
32. Phase II trial of combination intraperitoneal cisplatin and 5-fluorouracil in previously treated patients with advanced ovarian cancer: long-term follow-up.
Morgan RJ; Braly P; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Najera L; Johnson D; Doroshow JH
Gynecol Oncol; 2000 Jun; 77(3):433-8. PubMed ID: 10831355
[TBL] [Abstract][Full Text] [Related]
33. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
[TBL] [Abstract][Full Text] [Related]
34. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
[TBL] [Abstract][Full Text] [Related]
35. Case report: complete response of metastatic transitional cell carcinoma of the bladder with chemotherapy alone.
Dougherty WE; Lynch JH; Maxted WC
J Urol; 1984 Feb; 131(2):340-2. PubMed ID: 6538239
[TBL] [Abstract][Full Text] [Related]
36. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.
Logothetis CJ; Dexeus FH; Chong C; Sella A; Ayala AG; Ro JY; Pilat S
J Urol; 1989 Jan; 141(1):33-7. PubMed ID: 2908950
[TBL] [Abstract][Full Text] [Related]
38. Fallopian tube carcinoma: a clinicopathological study of 17 cases.
King A; Seraj IM; Thrasher T; Slater J; Wagner RJ
Gynecol Oncol; 1989 Jun; 33(3):351-5. PubMed ID: 2722062
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up.
Morgan RJ; Braly P; Cecchi G; Leong L; Shibata S; Margolin K; Somlo G; McNamara M; Longmate J; Schinke S; Raschko J; Nagasawa S; Kogut N; Parker P; Stein A; Cho J; Smith E; Coluzzi P; Najera L; Johnson D; Womack E; Doroshow JH
Gynecol Oncol; 1999 Dec; 75(3):419-26. PubMed ID: 10600300
[TBL] [Abstract][Full Text] [Related]
40. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
